Condition
Virus-HIV
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 10 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
10 shownPolypharmacy on Healthy Aging in People Living With HIV Over the Age of 75NCT07388394 · 2026-01-28
SUSPENDEDBecoming HIV-Exposed, Uninfected Children Born to HIV-Positive Mothers Followed at Bichat Claude Bernard HospitalNCT06666543 · 2024-03-20
COMPLETEDHIV A6 Genome In ART Unsuccessful Patients On DORNCT05322083 · 2022-05-01
UNKNOWNLife Experience of People Aged 60 and Over Living with HIVNCT05083273 · 2021-05-18
COMPLETEDSelf-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in MenNCT04772469 · 2021-03-22
COMPLETEDImpact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)NCT04581746 · 2020-11-25
UNKNOWNPrevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEPNCT04575545 · 2020-10-01
UNKNOWNMissed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIVNCT03671291 · 2019-04-03
COMPLETEDQDISS Stud: QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-PatientNCT03195452 · 2017-11-08
COMPLETEDCoronary Artery Disease (CAD) in Suppressed HIV-infectedNCT02898896 · 2017-03-01
TERMINATEDCommon interventions
blood testBIOLOGICAL1CohorteOTHER1DoravirineDRUG1interview with advanced practice nurseOTHER1Provision of multiple self-testsBEHAVIORAL1QuestionaryOTHER1questionnaireOTHER1Raltegravir and 2 Nucleoside/Nucleotide reverse transcriptase inhibitor (NRTI)DRUG1self-administrated questionnaireBEHAVIORAL1Serology test for COVID-19DIAGNOSTIC_TEST1Small monetary incentivesOTHER1Use of SMS/text reminders to motivate adherence to ART or PrEPBEHAVIORAL1
Leading sponsors
Assistance Publique - Hôpitaux de Paris
1
Centre Hospitalier Universitaire de Nice
1
French National Agency for Research on AIDS and Viral Hepatitis
1
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
1
Hôpital Européen Marseille
1
Hôpital NOVO
1
Nantes University Hospital
1
Tourcoing Hospital
1
University Hospital, Montpellier
1
University of California, San Francisco
1
Trial status mix
COMPLETED5
UNKNOWN3
SUSPENDED1
TERMINATED1
Phase mix
NA5
PHASE21
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.